Programmdetails - DGK Herztage 2025

Corticosteroid treatment in patients with newly diagnosed clinically silent cardiac sarcoidosis is associated with significantly improved long-term outcomes

J. Mörike (Ulm), D. Felbel (Ulm), M. Paukovitsch (Ulm), F. von Sanden (Ulm), W. Rottbauer (Ulm), D. Buckert (Ulm), N. Nita (Ulm)

Zum Abstract

Baseline patient-reported outcome results in patients with heart failure initiated on dapagliflozin: results of 2nd interim analysis of the non-interventional EVOLUTION-HF DEallEF study

M. Paul (Münster), A. Guth (Frankenthal), B. Subin (Hamburg), R. Bosch (Ludwigsburg), C. Zugck (Straubing), J. Langel (Gera), W. Richter (Essen), J. Taggeselle (Markkleeberg), M. Knapp (Schwäbisch Hall), S. H. Schirmer (Kaiserslautern), D. Weinrich (Berlin), C. Axthelm (Dresden), M. Klutmann (Aachen), M. Müller (Hamburg), B. Aßmus (Gießen)

Zum Abstract

Impact of guideline-directed medical therapy on LVEF-recovery in de novo HFrEF in females: analysis from a bicentric patient cohort

F. Post (Frankfurt am Main), V. Johnson (Frankfurt am Main), V. Buia (Fürth), L. Vitali-Serdoz (Fürth), C. Gold (Frankfurt am Main), A. Falagkari (Frankfurt am Main), H. Rittger (Fürth), L. Rottner (Frankfurt am Main), M. Papathanasiou (Frankfurt am Main), L. Schlender (Frankfurt am Main), D. Leistner (Frankfurt am Main), R. Wakili (Frankfurt am Main)

Zum Abstract

Divergent Ventricular Responses in HFpEF Call for Dual-Sided Therapeutic Strategies

H. Osman (Bochum), S. Delalat (Bochum), I. Sultana (Bochum), A. Mügge (Bochum), S. Zhazykbayeva (Bochum), M. Sieme (Bochum), I. Akin (Mannheim), P. Haldenwang (Bochum), I. El-Battrawy (Bochum), M. Khan (Amsterdamm), L. van Heerebeek (AC Amsterdam), N. Hamdani (Bochum)

Zum Abstract

Impact of Mavacamten on Bilateral Atrial and Ventricular Remodeling in Obstructive Hypertrophic Cardiomyopathy - Echocardiographic Analysis of a Real-World Cohort

F. Becker (München), C. Kustermann (München), J. Novotny (München), M. Orban (München), A. Lurz (München), B. Specht (München), F. Moeller-Dyrna (München), S. Kääb (München), L. Stolz (München), D. Reichart (München), E. L. H. Lindberg (München)

Zum Abstract

Vericiguat in der realen Welt: Welche Patient:innen sprechen an?

P. Horn (Bonn), L. Böhm (Bonn), H. Billig (Bonn), J. Vogelhuber (Bonn), G. Nickenig (Bonn), C. Öztürk (Bonn)

Zum Abstract

Real-World Disease Progression in Transthyretin Cardiac Amyloidosis: An Analysis Based on Consensus-Recommended Monitoring Parameters

Y. Metodiev (München), S. Alieva (München), S. Kääb (München), S. Schwarting (München)

Zum Abstract

Tafamidis induces improvement of right ventricle-to-pulmonary artery coupling in patients with transthyretin amyloid cardiomyopathy

J. Mörike (Ulm), D. Felbel (Ulm), M. Paukovitsch (Ulm), F. von Sanden (Ulm), W. Rottbauer (Ulm), D. Buckert (Ulm), N. Nita (Ulm)

Zum Abstract